MICSI · May 2026
NYU Entrepreneur profile highlighting MICSI’s AI-powered medical imaging work and current positioning.
Public company, workplace, funding, and market signals
MICSI (Microstructure Imaging Inc.) builds FDA-cleared software that upgrades existing MRI and PET scanners by denoising images, improving resolution, and reducing scan time. The company’s public positioning centers on making advanced imaging more accessible, more cost-effective, and more diagnostically powerful.
Primary product
MICSI-RMT
Founded
2018
Headquarters
New York City, New York, United States
Team size
1-10 employees
Industry
Technology, Information and Internet
Sub-industry
Medical imaging software
Offices
0 jobs at MICSI
Check back later for new openings
Business model
Stage
Seed
Total raised
$11.9M
Latest round
Grant (prize money) · Jan 2025
Leadership
Chief Executive Officer
Chief Technology Officer
Medical Advisor
Scientific Advisor
Scientific Advisor
Investors
Public materials suggest a small, research-driven, clinically oriented startup focused on translating academic MRI physics into FDA-cleared products, with an emphasis on publication-backed rigor and compliance/trust.
Pricing
Not publicly disclosed; appears to be demo-led enterprise software sales.
Differentiators
Technology
Customers
Competitors
Estimated revenue
≈$0.26M/year (third-party estimate)
Estimated monthly visits
1.4K
Traffic estimate as of Jul 2026
MICSI · May 2026
NYU Entrepreneur profile highlighting MICSI’s AI-powered medical imaging work and current positioning.
MICSI · Mar 2025
Company update on a reproducibility study showing denoising can reduce variability and sample-size requirements in diffusion MRI.
MICSI · Oct 2024
MICSI announced it was a semifinalist in two AuntMinnie radiology award categories.
MICSI · Sep 2024
Conference/news update that MICSI exhibited at RSNA 2024.
MICSI · Jul 2024
MICSI announced FDA 510(k) clearance for MICSI-RMT, its MRI image enhancement software.